VCYT FY 2020 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$117M-2.4% YoY

Gross Profit

$76M64.7% margin

Operating Income

-$35M-30.1% margin

Net Income

-$35M-29.7% margin

EPS (Diluted)

$-0.66

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$457M

Total Liabilities

$36M

Stockholders' Equity

$421M

Cash & Equivalents

$349M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$117M	$120M	-2.4%
Gross Profit	$76M	$84M	-9.3%
Operating Income	-$35M	-$15M	-133.9%
Net Income	-$35M	-$13M	-177.1%